116 related articles for article (PubMed ID: 10730886)
1. Monitoring of residual disease in non-Hodgkin's lymphomas by quantitative PCR (preliminary report).
Slavícková A; Ullmannová V; Benesová E; Klener P
Folia Biol (Praha); 1999; 45(5):179-83. PubMed ID: 10730886
[TBL] [Abstract][Full Text] [Related]
2. [Semiquantitative monitoring of molecular markers in non-Hodgkin's lymphoma].
Slavícková A; Benesová E; Bradová V; Ullmanová V
Cas Lek Cesk; 1997 Apr; 136(7):221-5. PubMed ID: 9221198
[TBL] [Abstract][Full Text] [Related]
3. [Clinical importance of semi-quantitative monitoring of lymphomas using the comparative polymerase chain reaction].
Slavícková A; Ivánek R; Cerný J; Sálková J; Trnĕný M
Cas Lek Cesk; 2002 Nov; 141(23):735-8. PubMed ID: 12650030
[TBL] [Abstract][Full Text] [Related]
4. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.
Schmitt C; Balogh B; Grundt A; Buchholtz C; Leo A; Benner A; Hensel M; Ho AD; Leo E
Leuk Res; 2006 Jun; 30(6):745-50. PubMed ID: 16297448
[TBL] [Abstract][Full Text] [Related]
5. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
6. Variability of quantitative polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicenter study.
Darby AJ; Lanham S; Soubeyran P; Johnson PW
Haematologica; 2005 Dec; 90(12):1706-7. PubMed ID: 16330451
[TBL] [Abstract][Full Text] [Related]
7. [Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene].
Matolcsy A; Borbényi Z; Demeter J; Egyed M; Fekete S; Földi J; Gergely L; Kajtár P; Kelényi G; Kiss A; László T; Lehoczky D; Losonczy H; Nagy M; Pál K; Pálóczy K; Radványi G; Semsei I; Varga G; Udvardy M
Orv Hetil; 2000 Jun; 141(25):1403-6. PubMed ID: 10934884
[TBL] [Abstract][Full Text] [Related]
8. Combined molecular diagnosis of B-cell lymphomas with t(11;14)(q13;q32) or t(14;18)(q32;q21) using multiplex- and long distance inverse-polymerase chain reaction.
Vieira L; Martinho A; Antunes O; Silva E; Ambrósio AP; Geraldes MC; Nascimento R; Silva C; Pereira JM; Júnior EC; Jordan P
Diagn Mol Pathol; 2008 Jun; 17(2):73-81. PubMed ID: 18382373
[TBL] [Abstract][Full Text] [Related]
9. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
[TBL] [Abstract][Full Text] [Related]
10. A non-isotopic nested polymerase chain reaction method to quantitate minimal residual disease in patients with non-Hodgkin's lymphoma.
Hétu F; Coutlée F; Roy DC
Mol Cell Probes; 1994 Dec; 8(6):449-57. PubMed ID: 7700265
[TBL] [Abstract][Full Text] [Related]
11. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
[TBL] [Abstract][Full Text] [Related]
12. Detection of minimal residual disease in patients with lymphomas using the polymerase chain reaction.
Gribben JG; Nadler LM
Important Adv Oncol; 1994; ():117-29. PubMed ID: 8206485
[No Abstract] [Full Text] [Related]
13. Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myeloma.
Novella E; Giaretta I; Elice F; Madeo D; Piccin A; Castaman G; Rodeghiero F
Haematologica; 2002 Nov; 87(11):1157-64. PubMed ID: 12414345
[TBL] [Abstract][Full Text] [Related]
14. Identification and structural analysis of rearranged immunoglobulin heavy chain genes in lymphomas and leukemias.
Linke B; Pyttlich J; Tiemann M; Suttorp M; Parwaresch R; Hiddemann W; Kneba M
Leukemia; 1995 May; 9(5):840-7. PubMed ID: 7769847
[TBL] [Abstract][Full Text] [Related]
15. Precast commercial polyacrylamide gels for separation of DNA amplificates by temperature gradient gel electrophoresis: application to clonality analysis of lymphomas.
Suttorp M; von Neuhoff N; Tiemann M; Dreger P; Schaub J; Löffer H; Parwaresch R; Schmitz N
Electrophoresis; 1996 Apr; 17(4):672-7. PubMed ID: 8738325
[TBL] [Abstract][Full Text] [Related]
16. Real-Time t(14;18)(q32;q21) PCR assay combined with high-resolution capillary electrophoresis: a novel and rapid approach that allows accurate quantitation and size determination of bcl-2/JH fusion sequences.
Sanchez-Vega B; Vega F; Hai S; Medeiros LJ; Luthra R
Mod Pathol; 2002 Apr; 15(4):448-53. PubMed ID: 11950920
[TBL] [Abstract][Full Text] [Related]
17. Follicular lymphoma: quantitation of minimal residual disease by PCR of the t(14;18) translocation.
Darby A; Gribben JG
Methods Mol Med; 2005; 115():315-31. PubMed ID: 15998976
[TBL] [Abstract][Full Text] [Related]
18. [Detection of residual disease in follicular lymphomas using the PCR technique: importance of clono-specific probes].
al Saati T; Galoin S; Roda D; Huynh A; Attal M; Delsol G
Bull Cancer; 1998 Oct; 85(10):847-54. PubMed ID: 9835862
[TBL] [Abstract][Full Text] [Related]
19. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
[TBL] [Abstract][Full Text] [Related]
20. Cytometric detection of DNA amplified with fluorescent primers: applications to analysis of clonal bcl-2 and IgH gene rearrangements in malignant lymphomas.
Barker RL; Worth CA; Peiper SC
Blood; 1994 Feb; 83(4):1079-85. PubMed ID: 8111048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
